Medite Cancer Diagnostics Inc. | Balance Sheet
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
Cash & Short Term Investments
1.00
230.00
587.00
108.00
490.00
Total Accounts Receivable
10.00
1,991.00
1,798.00
1,346.00
453.00
Inventories
-
3,415.00
3,075.00
3,811.00
2,403.00
Other Current Assets
5.00
154.00
186.00
79.00
118.00
Total Current Assets
16.00
5,790.00
5,646.00
5,344.00
3,464.00
Net Property, Plant & Equipment
5.00
2,091.00
1,941.00
1,557.00
1,778.00
Long-Term Note Receivable
-
-
-
25.00
-
Intangible Assets
-
10,518.00
10,518.00
10,518.00
10,518.00
Other Assets
-
245.00
273.00
151.00
196.00
Total Assets
21.00
18,644.00
18,378.00
17,545.00
15,956.00
ST Debt & Current Portion LT Debt
121.00
2,665.00
3,129.00
3,895.00
480.20
Accounts Payable
311.00
956.00
652.00
1,127.00
1,004.00
Other Current Liabilities
3,861.00
3,178.00
2,380.00
2,325.00
2,297.80
Total Current Liabilities
4,293.00
6,799.00
6,161.00
7,347.00
3,782.00
Long-Term Debt
-
1,209.00
846.00
195.00
4,914.00
Deferred Taxes
-
2,205.00
2,205.00
2,005.00
1,485.00
Total Liabilities
4,293.00
10,213.00
9,212.00
9,547.00
10,181.00
Common Equity (Total)
5,759.00
6,944.00
8,204.00
7,036.00
4,813.00
Total Shareholders' Equity
4,272.00
8,431.00
9,166.00
7,998.00
5,775.00
Total Equity
4,272.00
8,431.00
9,166.00
7,998.00
5,775.00
Liabilities & Shareholders' Equity
21.00
18,644.00
18,378.00
17,545.00
15,956.00
Preferred Stock (Carrying Value)
1,487.00
1,487.00
962.00
962.00
962.00
About Medite Cancer Diagnostics
View Profile
